ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antisense Oligonucleotides Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-6Y6097
Home | Market Reports | Science| Biological Sciences
Global Antisense Oligonucleotides Market Insights Forecast to 2028
BUY CHAPTERS

Global Antisense Oligonucleotides Market Research Report 2025

Code: QYRE-Auto-6Y6097
Report
June 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ionis Pharmaceuticals
Sarepta Therapeutics
Biogen
Alnylam Pharmaceuticals
Antisense Therapeutics
Isarna Therapeutics
Arrowhead Pharmaceuticals
Atlantic Pharmaceuticals
Enzon Pharmaceuticals
Bio-Path Holdings
GlaxoSmithKline PLC
Geron
iCo Therapeutics
Marina Biotech
RXi Pharmaceuticals

Antisense Oligonucleotides Market

The global market for Antisense Oligonucleotides was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Antisense oligonucleotides (ASOs) are 15–25 nt oligonucleotides designed to tie complementary RNA targets for the degradation. They are synthesized so that they can be used to block disease processes by altering the synthesis of a specific protein.
North American market for Antisense Oligonucleotides is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Antisense Oligonucleotides is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Antisense Oligonucleotides in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Antisense Oligonucleotides include Ionis Pharmaceuticals, Sarepta Therapeutics, Biogen, Alnylam Pharmaceuticals, Antisense Therapeutics, Isarna Therapeutics, Arrowhead Pharmaceuticals, Atlantic Pharmaceuticals, Enzon Pharmaceuticals, Bio-Path Holdings, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antisense Oligonucleotides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Oligonucleotides.
The Antisense Oligonucleotides market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antisense Oligonucleotides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antisense Oligonucleotides companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antisense Oligonucleotides Market Report

Report Metric Details
Report Name Antisense Oligonucleotides Market
Segment by Type
  • RNA Antisense Oligonucleotides
  • DNA Antisense Oligonucleotides
Segment by Application
  • Hospitals
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Ionis Pharmaceuticals, Sarepta Therapeutics, Biogen, Alnylam Pharmaceuticals, Antisense Therapeutics, Isarna Therapeutics, Arrowhead Pharmaceuticals, Atlantic Pharmaceuticals, Enzon Pharmaceuticals, Bio-Path Holdings, GlaxoSmithKline, Geron, ICO Therapeutics, Marina Biotech, RXi Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antisense Oligonucleotides company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antisense Oligonucleotides Market report?

Ans: The main players in the Antisense Oligonucleotides Market are Ionis Pharmaceuticals, Sarepta Therapeutics, Biogen, Alnylam Pharmaceuticals, Antisense Therapeutics, Isarna Therapeutics, Arrowhead Pharmaceuticals, Atlantic Pharmaceuticals, Enzon Pharmaceuticals, Bio-Path Holdings, GlaxoSmithKline, Geron, ICO Therapeutics, Marina Biotech, RXi Pharmaceuticals

What are the Application segmentation covered in the Antisense Oligonucleotides Market report?

Ans: The Applications covered in the Antisense Oligonucleotides Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the Antisense Oligonucleotides Market report?

Ans: The Types covered in the Antisense Oligonucleotides Market report are RNA Antisense Oligonucleotides, DNA Antisense Oligonucleotides

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antisense Oligonucleotides Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 RNA Antisense Oligonucleotides
1.2.3 DNA Antisense Oligonucleotides
1.3 Market by Application
1.3.1 Global Antisense Oligonucleotides Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antisense Oligonucleotides Market Perspective (2020-2031)
2.2 Global Antisense Oligonucleotides Growth Trends by Region
2.2.1 Global Antisense Oligonucleotides Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antisense Oligonucleotides Historic Market Size by Region (2020-2025)
2.2.3 Antisense Oligonucleotides Forecasted Market Size by Region (2026-2031)
2.3 Antisense Oligonucleotides Market Dynamics
2.3.1 Antisense Oligonucleotides Industry Trends
2.3.2 Antisense Oligonucleotides Market Drivers
2.3.3 Antisense Oligonucleotides Market Challenges
2.3.4 Antisense Oligonucleotides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense Oligonucleotides Players by Revenue
3.1.1 Global Top Antisense Oligonucleotides Players by Revenue (2020-2025)
3.1.2 Global Antisense Oligonucleotides Revenue Market Share by Players (2020-2025)
3.2 Global Antisense Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antisense Oligonucleotides Revenue
3.4 Global Antisense Oligonucleotides Market Concentration Ratio
3.4.1 Global Antisense Oligonucleotides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense Oligonucleotides Revenue in 2024
3.5 Global Key Players of Antisense Oligonucleotides Head office and Area Served
3.6 Global Key Players of Antisense Oligonucleotides, Product and Application
3.7 Global Key Players of Antisense Oligonucleotides, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense Oligonucleotides Breakdown Data by Type
4.1 Global Antisense Oligonucleotides Historic Market Size by Type (2020-2025)
4.2 Global Antisense Oligonucleotides Forecasted Market Size by Type (2026-2031)
5 Antisense Oligonucleotides Breakdown Data by Application
5.1 Global Antisense Oligonucleotides Historic Market Size by Application (2020-2025)
5.2 Global Antisense Oligonucleotides Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antisense Oligonucleotides Market Size (2020-2031)
6.2 North America Antisense Oligonucleotides Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antisense Oligonucleotides Market Size by Country (2020-2025)
6.4 North America Antisense Oligonucleotides Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antisense Oligonucleotides Market Size (2020-2031)
7.2 Europe Antisense Oligonucleotides Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antisense Oligonucleotides Market Size by Country (2020-2025)
7.4 Europe Antisense Oligonucleotides Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antisense Oligonucleotides Market Size (2020-2031)
8.2 Asia-Pacific Antisense Oligonucleotides Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antisense Oligonucleotides Market Size by Region (2020-2025)
8.4 Asia-Pacific Antisense Oligonucleotides Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antisense Oligonucleotides Market Size (2020-2031)
9.2 Latin America Antisense Oligonucleotides Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antisense Oligonucleotides Market Size by Country (2020-2025)
9.4 Latin America Antisense Oligonucleotides Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense Oligonucleotides Market Size (2020-2031)
10.2 Middle East & Africa Antisense Oligonucleotides Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antisense Oligonucleotides Market Size by Country (2020-2025)
10.4 Middle East & Africa Antisense Oligonucleotides Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ionis Pharmaceuticals
11.1.1 Ionis Pharmaceuticals Company Details
11.1.2 Ionis Pharmaceuticals Business Overview
11.1.3 Ionis Pharmaceuticals Antisense Oligonucleotides Introduction
11.1.4 Ionis Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2020-2025)
11.1.5 Ionis Pharmaceuticals Recent Development
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Details
11.2.2 Sarepta Therapeutics Business Overview
11.2.3 Sarepta Therapeutics Antisense Oligonucleotides Introduction
11.2.4 Sarepta Therapeutics Revenue in Antisense Oligonucleotides Business (2020-2025)
11.2.5 Sarepta Therapeutics Recent Development
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Biogen Business Overview
11.3.3 Biogen Antisense Oligonucleotides Introduction
11.3.4 Biogen Revenue in Antisense Oligonucleotides Business (2020-2025)
11.3.5 Biogen Recent Development
11.4 Alnylam Pharmaceuticals
11.4.1 Alnylam Pharmaceuticals Company Details
11.4.2 Alnylam Pharmaceuticals Business Overview
11.4.3 Alnylam Pharmaceuticals Antisense Oligonucleotides Introduction
11.4.4 Alnylam Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2020-2025)
11.4.5 Alnylam Pharmaceuticals Recent Development
11.5 Antisense Therapeutics
11.5.1 Antisense Therapeutics Company Details
11.5.2 Antisense Therapeutics Business Overview
11.5.3 Antisense Therapeutics Antisense Oligonucleotides Introduction
11.5.4 Antisense Therapeutics Revenue in Antisense Oligonucleotides Business (2020-2025)
11.5.5 Antisense Therapeutics Recent Development
11.6 Isarna Therapeutics
11.6.1 Isarna Therapeutics Company Details
11.6.2 Isarna Therapeutics Business Overview
11.6.3 Isarna Therapeutics Antisense Oligonucleotides Introduction
11.6.4 Isarna Therapeutics Revenue in Antisense Oligonucleotides Business (2020-2025)
11.6.5 Isarna Therapeutics Recent Development
11.7 Arrowhead Pharmaceuticals
11.7.1 Arrowhead Pharmaceuticals Company Details
11.7.2 Arrowhead Pharmaceuticals Business Overview
11.7.3 Arrowhead Pharmaceuticals Antisense Oligonucleotides Introduction
11.7.4 Arrowhead Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2020-2025)
11.7.5 Arrowhead Pharmaceuticals Recent Development
11.8 Atlantic Pharmaceuticals
11.8.1 Atlantic Pharmaceuticals Company Details
11.8.2 Atlantic Pharmaceuticals Business Overview
11.8.3 Atlantic Pharmaceuticals Antisense Oligonucleotides Introduction
11.8.4 Atlantic Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2020-2025)
11.8.5 Atlantic Pharmaceuticals Recent Development
11.9 Enzon Pharmaceuticals
11.9.1 Enzon Pharmaceuticals Company Details
11.9.2 Enzon Pharmaceuticals Business Overview
11.9.3 Enzon Pharmaceuticals Antisense Oligonucleotides Introduction
11.9.4 Enzon Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2020-2025)
11.9.5 Enzon Pharmaceuticals Recent Development
11.10 Bio-Path Holdings
11.10.1 Bio-Path Holdings Company Details
11.10.2 Bio-Path Holdings Business Overview
11.10.3 Bio-Path Holdings Antisense Oligonucleotides Introduction
11.10.4 Bio-Path Holdings Revenue in Antisense Oligonucleotides Business (2020-2025)
11.10.5 Bio-Path Holdings Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Antisense Oligonucleotides Introduction
11.11.4 GlaxoSmithKline Revenue in Antisense Oligonucleotides Business (2020-2025)
11.11.5 GlaxoSmithKline Recent Development
11.12 Geron
11.12.1 Geron Company Details
11.12.2 Geron Business Overview
11.12.3 Geron Antisense Oligonucleotides Introduction
11.12.4 Geron Revenue in Antisense Oligonucleotides Business (2020-2025)
11.12.5 Geron Recent Development
11.13 ICO Therapeutics
11.13.1 ICO Therapeutics Company Details
11.13.2 ICO Therapeutics Business Overview
11.13.3 ICO Therapeutics Antisense Oligonucleotides Introduction
11.13.4 ICO Therapeutics Revenue in Antisense Oligonucleotides Business (2020-2025)
11.13.5 ICO Therapeutics Recent Development
11.14 Marina Biotech
11.14.1 Marina Biotech Company Details
11.14.2 Marina Biotech Business Overview
11.14.3 Marina Biotech Antisense Oligonucleotides Introduction
11.14.4 Marina Biotech Revenue in Antisense Oligonucleotides Business (2020-2025)
11.14.5 Marina Biotech Recent Development
11.15 RXi Pharmaceuticals
11.15.1 RXi Pharmaceuticals Company Details
11.15.2 RXi Pharmaceuticals Business Overview
11.15.3 RXi Pharmaceuticals Antisense Oligonucleotides Introduction
11.15.4 RXi Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2020-2025)
11.15.5 RXi Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Ionis Pharmaceuticals
Sarepta Therapeutics
Biogen
Alnylam Pharmaceuticals
Antisense Therapeutics
Isarna Therapeutics
Arrowhead Pharmaceuticals
Atlantic Pharmaceuticals
Enzon Pharmaceuticals
Bio-Path Holdings
GlaxoSmithKline PLC
Geron
iCo Therapeutics
Marina Biotech
RXi Pharmaceuticals
List of Tables
 Table 1. Global Antisense Oligonucleotides Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of RNA Antisense Oligonucleotides
 Table 3. Key Players of DNA Antisense Oligonucleotides
 Table 4. Global Antisense Oligonucleotides Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Antisense Oligonucleotides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Antisense Oligonucleotides Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Antisense Oligonucleotides Market Share by Region (2020-2025)
 Table 8. Global Antisense Oligonucleotides Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Antisense Oligonucleotides Market Share by Region (2026-2031)
 Table 10. Antisense Oligonucleotides Market Trends
 Table 11. Antisense Oligonucleotides Market Drivers
 Table 12. Antisense Oligonucleotides Market Challenges
 Table 13. Antisense Oligonucleotides Market Restraints
 Table 14. Global Antisense Oligonucleotides Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Antisense Oligonucleotides Market Share by Players (2020-2025)
 Table 16. Global Top Antisense Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotides as of 2024)
 Table 17. Ranking of Global Top Antisense Oligonucleotides Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Antisense Oligonucleotides Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Antisense Oligonucleotides, Headquarters and Area Served
 Table 20. Global Key Players of Antisense Oligonucleotides, Product and Application
 Table 21. Global Key Players of Antisense Oligonucleotides, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Antisense Oligonucleotides Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Antisense Oligonucleotides Revenue Market Share by Type (2020-2025)
 Table 25. Global Antisense Oligonucleotides Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Antisense Oligonucleotides Revenue Market Share by Type (2026-2031)
 Table 27. Global Antisense Oligonucleotides Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Antisense Oligonucleotides Revenue Market Share by Application (2020-2025)
 Table 29. Global Antisense Oligonucleotides Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Antisense Oligonucleotides Revenue Market Share by Application (2026-2031)
 Table 31. North America Antisense Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Antisense Oligonucleotides Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Antisense Oligonucleotides Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Antisense Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Antisense Oligonucleotides Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Antisense Oligonucleotides Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Antisense Oligonucleotides Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Antisense Oligonucleotides Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Antisense Oligonucleotides Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Antisense Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Antisense Oligonucleotides Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Antisense Oligonucleotides Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Antisense Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Antisense Oligonucleotides Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Antisense Oligonucleotides Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Ionis Pharmaceuticals Company Details
 Table 47. Ionis Pharmaceuticals Business Overview
 Table 48. Ionis Pharmaceuticals Antisense Oligonucleotides Product
 Table 49. Ionis Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 50. Ionis Pharmaceuticals Recent Development
 Table 51. Sarepta Therapeutics Company Details
 Table 52. Sarepta Therapeutics Business Overview
 Table 53. Sarepta Therapeutics Antisense Oligonucleotides Product
 Table 54. Sarepta Therapeutics Revenue in Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 55. Sarepta Therapeutics Recent Development
 Table 56. Biogen Company Details
 Table 57. Biogen Business Overview
 Table 58. Biogen Antisense Oligonucleotides Product
 Table 59. Biogen Revenue in Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 60. Biogen Recent Development
 Table 61. Alnylam Pharmaceuticals Company Details
 Table 62. Alnylam Pharmaceuticals Business Overview
 Table 63. Alnylam Pharmaceuticals Antisense Oligonucleotides Product
 Table 64. Alnylam Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 65. Alnylam Pharmaceuticals Recent Development
 Table 66. Antisense Therapeutics Company Details
 Table 67. Antisense Therapeutics Business Overview
 Table 68. Antisense Therapeutics Antisense Oligonucleotides Product
 Table 69. Antisense Therapeutics Revenue in Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 70. Antisense Therapeutics Recent Development
 Table 71. Isarna Therapeutics Company Details
 Table 72. Isarna Therapeutics Business Overview
 Table 73. Isarna Therapeutics Antisense Oligonucleotides Product
 Table 74. Isarna Therapeutics Revenue in Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 75. Isarna Therapeutics Recent Development
 Table 76. Arrowhead Pharmaceuticals Company Details
 Table 77. Arrowhead Pharmaceuticals Business Overview
 Table 78. Arrowhead Pharmaceuticals Antisense Oligonucleotides Product
 Table 79. Arrowhead Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 80. Arrowhead Pharmaceuticals Recent Development
 Table 81. Atlantic Pharmaceuticals Company Details
 Table 82. Atlantic Pharmaceuticals Business Overview
 Table 83. Atlantic Pharmaceuticals Antisense Oligonucleotides Product
 Table 84. Atlantic Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 85. Atlantic Pharmaceuticals Recent Development
 Table 86. Enzon Pharmaceuticals Company Details
 Table 87. Enzon Pharmaceuticals Business Overview
 Table 88. Enzon Pharmaceuticals Antisense Oligonucleotides Product
 Table 89. Enzon Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 90. Enzon Pharmaceuticals Recent Development
 Table 91. Bio-Path Holdings Company Details
 Table 92. Bio-Path Holdings Business Overview
 Table 93. Bio-Path Holdings Antisense Oligonucleotides Product
 Table 94. Bio-Path Holdings Revenue in Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 95. Bio-Path Holdings Recent Development
 Table 96. GlaxoSmithKline Company Details
 Table 97. GlaxoSmithKline Business Overview
 Table 98. GlaxoSmithKline Antisense Oligonucleotides Product
 Table 99. GlaxoSmithKline Revenue in Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 100. GlaxoSmithKline Recent Development
 Table 101. Geron Company Details
 Table 102. Geron Business Overview
 Table 103. Geron Antisense Oligonucleotides Product
 Table 104. Geron Revenue in Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 105. Geron Recent Development
 Table 106. ICO Therapeutics Company Details
 Table 107. ICO Therapeutics Business Overview
 Table 108. ICO Therapeutics Antisense Oligonucleotides Product
 Table 109. ICO Therapeutics Revenue in Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 110. ICO Therapeutics Recent Development
 Table 111. Marina Biotech Company Details
 Table 112. Marina Biotech Business Overview
 Table 113. Marina Biotech Antisense Oligonucleotides Product
 Table 114. Marina Biotech Revenue in Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 115. Marina Biotech Recent Development
 Table 116. RXi Pharmaceuticals Company Details
 Table 117. RXi Pharmaceuticals Business Overview
 Table 118. RXi Pharmaceuticals Antisense Oligonucleotides Product
 Table 119. RXi Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 120. RXi Pharmaceuticals Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Antisense Oligonucleotides Picture
 Figure 2. Global Antisense Oligonucleotides Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antisense Oligonucleotides Market Share by Type: 2024 VS 2031
 Figure 4. RNA Antisense Oligonucleotides Features
 Figure 5. DNA Antisense Oligonucleotides Features
 Figure 6. Global Antisense Oligonucleotides Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Antisense Oligonucleotides Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Clinic Case Studies
 Figure 10. Others Case Studies
 Figure 11. Antisense Oligonucleotides Report Years Considered
 Figure 12. Global Antisense Oligonucleotides Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Antisense Oligonucleotides Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Antisense Oligonucleotides Market Share by Region: 2024 VS 2031
 Figure 15. Global Antisense Oligonucleotides Market Share by Players in 2024
 Figure 16. Global Top Antisense Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotides as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Antisense Oligonucleotides Revenue in 2024
 Figure 18. North America Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Antisense Oligonucleotides Market Share by Country (2020-2031)
 Figure 20. United States Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Antisense Oligonucleotides Market Share by Country (2020-2031)
 Figure 24. Germany Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Antisense Oligonucleotides Market Share by Region (2020-2031)
 Figure 32. China Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Antisense Oligonucleotides Market Share by Country (2020-2031)
 Figure 40. Mexico Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Antisense Oligonucleotides Market Share by Country (2020-2031)
 Figure 44. Turkey Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Ionis Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2020-2025)
 Figure 48. Sarepta Therapeutics Revenue Growth Rate in Antisense Oligonucleotides Business (2020-2025)
 Figure 49. Biogen Revenue Growth Rate in Antisense Oligonucleotides Business (2020-2025)
 Figure 50. Alnylam Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2020-2025)
 Figure 51. Antisense Therapeutics Revenue Growth Rate in Antisense Oligonucleotides Business (2020-2025)
 Figure 52. Isarna Therapeutics Revenue Growth Rate in Antisense Oligonucleotides Business (2020-2025)
 Figure 53. Arrowhead Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2020-2025)
 Figure 54. Atlantic Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2020-2025)
 Figure 55. Enzon Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2020-2025)
 Figure 56. Bio-Path Holdings Revenue Growth Rate in Antisense Oligonucleotides Business (2020-2025)
 Figure 57. GlaxoSmithKline Revenue Growth Rate in Antisense Oligonucleotides Business (2020-2025)
 Figure 58. Geron Revenue Growth Rate in Antisense Oligonucleotides Business (2020-2025)
 Figure 59. ICO Therapeutics Revenue Growth Rate in Antisense Oligonucleotides Business (2020-2025)
 Figure 60. Marina Biotech Revenue Growth Rate in Antisense Oligonucleotides Business (2020-2025)
 Figure 61. RXi Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Antisense Oligonucleotides based Therapeutics Market Research Report 2024
Global Antisense ODN Market Research Report 2024
Global Antisense Oligonucleotides ASO Therapy Market Research Report 2024
Global Antisense Oligonucleotide Therapy for the Nervous System Market Research Report 2024
Global ASO based Drug Market Research Report 2024
Global Antisense Oligonucleotides ASOs Drugs Market Research Report 2024
Global Antisense Oligonucleotide Service Market Research Report 2025
Global Antisense Oligonucleotides ASO Drug Market Research Report 2024
Global Antisense oligonucleotides ASO Drug and siRNA Drug Market Research Report 2024
Antisense Oligonucleotide ASO Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CNS Specific Antisense Oligonucleotides Market Research Report 2024
Global Antisense Oligonucleotides Drugs for ATTR Market Research Report 2024
Global Oligonucleotide Drugs ONs Market Research Report 2025
Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oligonucleotide Oligo Drugs Market Research Report 2024
Global Oligonucleotides Market Insights Forecast to 2030
Global Oligonucleotide Therapeutics Market Research Report 2024
Global Oligonucleotide Market Research Report 2025
Global Antibody oligonucleotide Conjugates AOCs Market Research Report 2024
Global Nucleic Acid Drugs Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions